Identification and functional analysis of Hyphantria cunea nucleopolyhedrovirus iap genes
Description
Hyphantria cunea nucleopolyhedrovirus (HycuNPV) infection protected SpIm cells from actinomycin D (ActD)-induced apoptosis as early as 4 h postinfection. Analysis by Southern hybridization revealed that the HycuNPV genome possessed three members of inhibitor of apoptosis genes (iaps) that were designated as hycu-iap1, hycu-iap2, and hycu-iap3 because of their amino acid sequence homology with iaps identified in other baculoviruses. Functional analysis of Hycu-IAPs by transient expression assay in Sf9 cells revealed that Hycu-IAP3 blocked apoptosis induced by actinomycin D and rescued replication of p35 deficient-mutant AcMNPV, while Hycu-IAP1 and Hycu-IAP2 did not show any anti-apoptotic functions. Knockdown of hycu-iap3 expression by RNAi during HycuNPV infection in SpIm cells induced apoptosis. These results indicate that Hycu-IAP3 is essential for blockage of apoptosis during HycuNPV infection of permissive SpIm cells
Additional details
Identifiers
- DOI
- 10.1016/j.virol.2004.01.002;
- PII
- S0042682204000224;
Publishing Information
- Journal Title
- Virology
- Journal Volume
- 321
- Journal Issue
- 2
- Journal Page Range
- p. 359-371
- ISSN
- 0042-6822
- CODEN
- VIRLAX
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 35068148
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ACTINOMYCIN; AMINO ACID SEQUENCE; APOPTOSIS; FUNCTIONAL ANALYSIS; GENES; MUTANTS; PHOSPHORUS 35; TRANSIENTS; VIRUSES
- Descriptors DEC
- ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTIMITOTIC DRUGS; ANTINEOPLASTIC DRUGS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DRUGS; ISOTOPES; LIGHT NUCLEI; MATHEMATICS; MICROORGANISMS; MOLECULAR STRUCTURE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; PARASITES; PHOSPHORUS ISOTOPES; RADIOISOTOPES; SECONDS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.